Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia
Cellular Oncology · 2023-12 · 46 (6) · 1709-1724
DOI: 10.1007/s13402-023-00837-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 24.07.2023. Verfasst von Yanxin Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fu…. Hauptthemen laut MEDLINE: Phosphoproteins, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China, Joint Funds for the innovation of science and Technology,Fujian province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian, 350001, China.
- Haematology Research Centre, Department of Immunology and Inflammation, Imperial college London, South Kensington Campus, London, SW7 2AZ, UK.
- Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian, 350001, China. yang.hopeting@gmail.com.
- Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian, 350001, China. drjiandahu@163.com.
Förderung
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
- Joint Funds for the innovation of science and Technology,Fujian province
Zitieren
APA
Chen, Y., Wu, Z., Wang, L., Lin, M., Jiang, P., Wen, J., Li, J., Hong, Y., Zheng, X., Yang, X., Zheng, J., Gale, R. P., Yang, T., & Hu, J. (2023). Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia. Cellular Oncology, 46(6), 1709-1724. https://doi.org/10.1007/s13402-023-00837-2
Vancouver
Chen Y, Wu Z, Wang L, Lin M, Jiang P, Wen J, et al. Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia. Cellular Oncology. 2023;46(6):1709-1724. doi:10.1007/s13402-023-00837-2
BibTeX
@article{Chen2023,
author = {Chen, Yanxin and Wu, Zhengjun and Wang, Lingyan and Lin, Minhui and Jiang, Peifang and Wen, Jingjing and Li, Jiazheng and Hong, Yunda and Zheng, Xiaoyun and Yang, Xiaozhu and Zheng, Jing and Gale, Robert Peter and Yang, Ting and Hu, Jianda},
title = {Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia},
journal = {Cellular Oncology},
year = {2023},
volume = {46},
number = {6},
pages = {1709--1724},
doi = {10.1007/s13402-023-00837-2}
}
EUVIMED